Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$1.60

-0.185 (-10.39%)

19:13
11/13/19
11/13
19:13
11/13/19
19:13

BioCryst 37.93M share Secondary priced at $1.45

The deal priced below the last closing price of $1.58. JPMorgan is acting as lead book running manager for the offering.

  • 14

    Nov

BCRX BioCryst
$1.60

-0.185 (-10.39%)

05/24/19
RBCM
05/24/19
DOWNGRADE
Target $4.5
RBCM
Sector Perform
BioCryst downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital analyst Brian Abrahams downgraded BioCryst Pharmaceuticals to Sector Perform from Outperform and lowered his price target for the shares to $4.50 from $16.
05/24/19
05/24/19
DOWNGRADE
Target $4.5

Sector Perform
BioCryst downgraded to Sector Perform at RBC Capital on disappointing '7353 data
As previously reported, RBC Capital analyst Brian Abrahams downgraded BioCryst to Sector Perform from Outperform and lowered his price target to $4.50 from $16. The analyst cites the "disappointing" efficacy data for BCX7353, relegating the drug's potential to a "smaller niche role" even with discount pricing. Abrahams adds that although approvability risks for '7353 may be unfounded and the stock may bounce, he believes that the Street will have to turn more confident about its future revenues to offset the investments in filing and commercialization.
08/06/19
PIPR
08/06/19
NO CHANGE
Target $10
PIPR
Overweight
Piper Jaffray remains bullish on BioCryst, sees BCX7353 as viable product
Piper Jaffray analyst Tyler Van Buren reiterates an Overweight rating and $10 price target on BioCryst as he believes BCX7353 is a "viable product," while the rest of the pipeline is receiving little to no value. Having less than 12 months of cash is "clearly weighing" on the shares as the company heads toward a product launch in HAE prophylaxis, he acknowledges, but adds that he believes the company has several creative options at its disposal in addition to a potential strategic deal for ex-U.S. rights.
11/06/19
PIPR
11/06/19
NO CHANGE
Target $10
PIPR
Overweight
Piper says BCX7353 'viable,' BioCryst not getting credit for rest of pipeline
Piper Jaffray analyst Tyler Van Buren said following the presentation of new data showing that BCX7353 continues to show sustained efficacy through 48 weeks, he believes BCX7353 is an "approvable, viable" product that is also demonstrating durability. BioCryst also has several other products in the pipeline - such as BCX9930 and BCX9350 - are receiving no value from investors, added Van Buren, who keeps an Overweight rating and $10 price target on the shares.

TODAY'S FREE FLY STORIES

ISTR

Investar Holding

$25.55

0.73 (2.94%)

07:51
12/09/19
12/09
07:51
12/09/19
07:51
Downgrade
Investar Holding rating change  »

Investar Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBK

FB Financial

$39.58

0.86 (2.22%)

07:50
12/09/19
12/09
07:50
12/09/19
07:50
Downgrade
FB Financial rating change  »

FB Financial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$353.99

8.295 (2.40%)

07:49
12/09/19
12/09
07:49
12/09/19
07:49
Recommendations
Boeing analyst commentary  »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$233.74

0.3 (0.13%)

, BGNE

BeiGene

$186.89

-2.3 (-1.22%)

07:47
12/09/19
12/09
07:47
12/09/19
07:47
Recommendations
Amgen, BeiGene analyst commentary  »

Amgen price target raised…

AMGN

Amgen

$233.74

0.3 (0.13%)

BGNE

BeiGene

$186.89

-2.3 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 27

    Feb

AMTD

TD Ameritrade

$51.12

0.32 (0.63%)

, SCHW

Charles Schwab

$48.95

0.22 (0.45%)

07:45
12/09/19
12/09
07:45
12/09/19
07:45
Downgrade
TD Ameritrade, Charles Schwab rating change  »

TD Ameritrade shares…

AMTD

TD Ameritrade

$51.12

0.32 (0.63%)

SCHW

Charles Schwab

$48.95

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFF

International Flavors

$142.03

0.21 (0.15%)

, DD

DuPont

$63.60

1.6 (2.58%)

07:45
12/09/19
12/09
07:45
12/09/19
07:45
Recommendations
International Flavors, DuPont analyst commentary  »

International Flavors…

IFF

International Flavors

$142.03

0.21 (0.15%)

DD

DuPont

$63.60

1.6 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBIO

Mustang Bio

$3.86

0.025 (0.65%)

07:44
12/09/19
12/09
07:44
12/09/19
07:44
Hot Stocks
Mustang Bio: Lentiviral gene therapy with busulfan conditioning 'well tolerated' »

Mustang Bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

07:44
12/09/19
12/09
07:44
12/09/19
07:44
Recommendations
Bluebird Bio analyst commentary  »

Bluebird Bio price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AM

Antero Midstream

$4.49

-0.025 (-0.55%)

, AR

Antero Resources

$2.18

0.09 (4.31%)

07:43
12/09/19
12/09
07:43
12/09/19
07:43
Hot Stocks
Antero Midstream to purchase $100M of shares from Antero Resources »

Antero Midstream (AM)…

AM

Antero Midstream

$4.49

-0.025 (-0.55%)

AR

Antero Resources

$2.18

0.09 (4.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCN

FTI Consulting

$111.68

0.28 (0.25%)

07:42
12/09/19
12/09
07:42
12/09/19
07:42
Hot Stocks
FTI Consulting enters partnership with Brainspace »

FTI Consulting announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBIO

BridgeBio

$33.03

0.8 (2.48%)

07:41
12/09/19
12/09
07:41
12/09/19
07:41
Hot Stocks
BridgeBio appoints Eli Wallace as chief scientific officer for oncology »

BridgeBio Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,339.41

11.6 (0.87%)

07:40
12/09/19
12/09
07:40
12/09/19
07:40
Recommendations
Alphabet Class A analyst commentary  »

Alphabet shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:40
12/09/19
12/09
07:40
12/09/19
07:40
General news
Treasury Market Outlook: equities have dipped lower in quiet trade »

Treasury Market Outlook:…

EPD

Enterprise Products

$26.25

0.18 (0.69%)

, ENB

Enbridge

$38.52

0.015 (0.04%)

07:39
12/09/19
12/09
07:39
12/09/19
07:39
Hot Stocks
Enterprise Products, Enbridge sign LOI to jointly develop deepwater terminal »

Enterprise Products…

EPD

Enterprise Products

$26.25

0.18 (0.69%)

ENB

Enbridge

$38.52

0.015 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

BLK

BlackRock

$495.78

5.6 (1.14%)

07:39
12/09/19
12/09
07:39
12/09/19
07:39
Conference/Events
BlackRock management to meet with Oppenheimer »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 26

    Feb

HBIO

Harvard Bioscience

$2.95

0.01 (0.34%)

07:38
12/09/19
12/09
07:38
12/09/19
07:38
Downgrade
Harvard Bioscience rating change  »

Harvard Bioscience…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SESN

Sesen Bio

$1.19

-0.01 (-0.84%)

07:37
12/09/19
12/09
07:37
12/09/19
07:37
Hot Stocks
Sesen Bio initiates rolling submission of BLA for Vicinium to FDA »

Sesen Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BC

Brunswick

$59.81

0.89 (1.51%)

07:36
12/09/19
12/09
07:36
12/09/19
07:36
Conference/Events
Brunswick management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SSKN

Strata Skin Sciences

$2.16

(0.00%)

07:36
12/09/19
12/09
07:36
12/09/19
07:36
Initiation
Strata Skin Sciences initiated  »

Strata Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Dec

AUB

Atlantic Union Bankshares

$37.82

0.45 (1.20%)

07:35
12/09/19
12/09
07:35
12/09/19
07:35
Conference/Events
Atlantic Union Bankshares management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

ENB

Enbridge

$38.52

0.015 (0.04%)

, EPD

Enterprise Products

$26.25

0.18 (0.69%)

07:35
12/09/19
12/09
07:35
12/09/19
07:35
Hot Stocks
Enbridge, Enterprise Products to jointly develop crude oil export terminal »

Enbridge (ENB) and…

ENB

Enbridge

$38.52

0.015 (0.04%)

EPD

Enterprise Products

$26.25

0.18 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

07:35
12/09/19
12/09
07:35
12/09/19
07:35
General news
FX Update: The dollar lost ground to the yen and pound »

FX Update: The dollar…

TGTX

TG Therapeutics

$7.11

-0.57 (-7.42%)

07:34
12/09/19
12/09
07:34
12/09/19
07:34
Recommendations
TG Therapeutics analyst commentary  »

TG Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AMPY

Amplify Energy

$5.39

0.14 (2.67%)

07:33
12/09/19
12/09
07:33
12/09/19
07:33
Conference/Events
Amplify Energy management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ETNB

89bio

$28.38

0.86 (3.13%)

07:33
12/09/19
12/09
07:33
12/09/19
07:33
Initiation
89bio initiated  »

89bio initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.